Jasper Therapeutics (JSPR)
NASDAQ:JSPR
US Market
Holding JSPR?
Track your performance easily

Jasper Therapeutics (JSPR) Financial Statements

581 Followers

Jasper Therapeutics Financial Overview

Jasper Therapeutics's market cap is currently ―. The company's EPS TTM is $-4.746; its P/E ratio is -5.17; Jasper Therapeutics is scheduled to report earnings on March 11, 2025, and the estimated EPS forecast is $-1.26. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -18.64M$ -14.58M$ -19.36M$ -16.08M$ -14.26M
EBITDA$ -18.14M$ -14.27M$ -19.09M$ -15.85M$ -13.99M
Net Income Common Stockholders$ -18.64M$ -14.58M$ -17.54M$ -16.08M$ -9.35M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 92.50M$ 106.82M$ 103.87M$ 115.80M$ 129.40M
Total Assets$ 99.41M$ 113.93M$ 110.41M$ 124.16M$ 138.76M
Total Debt$ 2.07M$ 2.32M$ 3.01M$ 3.23M$ 3.44M
Net Debt$ -90.43M$ -104.50M$ -100.85M$ -112.57M$ -125.95M
Total Liabilities$ 15.73M$ 13.62M$ 16.27M$ 13.96M$ 13.56M
Stockholders Equity$ 83.68M$ 100.31M$ 94.13M$ 110.20M$ 125.20M
Cash Flow-
Free Cash Flow$ -14.34M$ -11.86M$ -11.98M$ -13.28M$ -10.36M
Operating Cash Flow$ -14.07M$ -11.70M$ -11.98M$ -13.27M$ -10.34M
Investing Cash Flow$ -274.00K$ -157.00K-$ -11.00K$ -26.00K
Financing Cash Flow$ 9.00K$ 181.00K$ 36.00K$ -305.00K$ 101.51M
Currency in USD

Jasper Therapeutics Earnings and Revenue History

Jasper Therapeutics Debt to Assets

Jasper Therapeutics Cash Flow

Jasper Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis